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Inflammatory Bowel Disease in Travelers
G&H  Why are inflammatory bowel disease 
patients at higher risk for infection, including 
opportunistic infection?
GR  The risk of infection is higher in patients with inflam-
matory bowel disease (IBD) than in the general popula-
tion. This includes opportunistic infections that can be 
contracted while traveling, as well as infections that may 
occur anywhere, such as Clostridium difficile infection and 
cytomegalovirus colitis. One reason for the increased risk 
of infection is that many IBD patients are on immunosup-
pressive or corticosteroid therapy. Both therapies reduce 
the activity of the immune system, meaning that the 
defense against invading microbes is reduced and that the 
microbes can better proliferate and infect cells. Another 
reason is that when IBD patients have active disease asso-
ciated with an impaired mucosal barrier function, they are 
at increased risk of opportunistic infections. An inflamed 
gut is a site of leakage of bacteria, fungi, or viruses into the 
body, which increases the risk of developing an infection. 
G&H  What are some of the common infections, 
particularly opportunistic infections, for which 
traveling IBD patients may be at risk? 
GR  Infectious risks depend upon the particular area being 
visited. For example, in Mexico and countries in Central 
America, there is a high risk of developing Escherichia coli 
infection and subsequent enteritis. In contrast, there is a 
high prevalence of tuberculosis in India, Pakistan, Afghan-
istan, and certain areas of South Africa. Even within a 
country with a high risk of an opportunistic infection, the 
risk will depend upon the particular areas being visited. 
For example, the risk of acquiring an infection is usually 
lowest in tourist areas. In addition, infectious risks may 
change every few weeks. For instance, there is currently 
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... it is important to check 
that IBD patients have 
received all routine age-
appropriate vaccines ...
a high risk of yellow fever in several countries in Africa 
and South America, even in some cities that were free of 
this disease in the past (eg, Rio de Janeiro, São Paulo). 
Generally speaking, in developed countries, there is not a 
high risk of opportunistic infections. 
Thus, I recommend that every IBD patient (or any 
patient on immunosuppressive therapy) who is planning 
to travel should visit a travel medicine center or special-
ist to learn which infections may be encountered in the 
area(s) being visited (eg, in addition to the abovemen-
tioned infections, infections may include malaria, enteric 
fever, rabies, Japanese encephalitis, and tick-borne 
encephalitis) and what preventive measures (particularly 
vaccines) should be undertaken. Education about the 
risks of traveling and the need for vaccination is very 
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important, but often not covered well enough. General 
gastroenterologists often overlook these issues, thinking 
that they are too specific and complicated to deal with. 
In addition, it is difficult for gastroenterologists who do 
recognize the importance of these issues to always be 
updated, so visiting a travel medicine center or specialist 
is vital for patients to obtain the most recent and effective 
advice for travel. 
G&H  What vaccines are recommended for IBD 
patients before they travel?
GR  First of all, it is important to check that IBD patients 
have received all routine age-appropriate vaccines, such as 
for hepatitis A and B; human papilloma virus; meningo-
a live vaccine can be given at that point in centers with 
experienced doctors. Otherwise, it is recommended 
that patients wait at least 3 months after cessation of 
... a Swiss study examined 
10 insect repellents and 
found that only 3 were 
effective. 
coccus; and measles, mumps, and rubella. Routine vaccina-
tions should also include pneumococcal vaccination and an 
annual influenza vaccination. IBD patients should receive 
varicella-zoster vaccination before undergoing immuno-
suppressive therapy. In addition, IBD patients who travel 
a lot should probably receive yellow fever vaccination even 
if they do not have specific traveling plans within the next 
year because this vaccination is difficult to administer once 
patients start immunosuppressive therapy. Finally, specific 
vaccines may be recommended for travel to certain areas, 
which is why it is important to visit a travel medicine center 
or specialist to learn which vaccines are needed and which 
are not. 
G&H  How successful is vaccination in IBD 
patients? 
GR  Several studies have shown that the success rate of 
a vaccination is a little lower in patients on anti–tumor 
necrosis factor (TNF) therapy (with a difference of 
approximately 10% reported). With respect to the dura-
tion of the vaccination, I am not aware of any data show-
ing that the protection is shorter in immunosuppressed 
patients.
G&H  How safe are live vaccines in 
immunosuppressed IBD patients?
GR  In Switzerland, a recent recommendation was 
made on behalf of the Federal Advisory Commission on 
Immunisation and was endorsed by the Swiss Society for 
Gastroenterology that immunosuppressed patients who 
need a live vaccine can receive it in certain situations. 
For example, if an immunosuppressed IBD patient needs 
yellow fever vaccination, an inactivated vaccine, such 
as for influenza, should be given first. If the patient’s 
response is sufficient to that vaccination and his or her T 
helper cell count is above 200, then in special situations 
immunosuppression to receive a live vaccine, or that they 
wait at least 4 weeks from the time of the vaccination 
before they can start immunosuppressive therapy. 
G&H  What preventive measures can IBD patients 
use while they are traveling?
GR  Travel medicine centers and specialists can offer 
IBD patients many useful traveling recommendations. 
For example, IBD patients should be advised on proper 
hygiene, such as only eating fruits or salads that they know 
have been washed with clean water, and they should take 
care to avoid contaminated water. However, adherence to 
these recommendations is often low. 
G&H  Are there also recommendations on how 
to avoid insect or animal bites that could cause 
infections?
GR  Yes, this is another important aspect of prevention. 
The best way to avoid yellow fever, as well as Zika fever 
and Dengue fever (the latter 2 of which there are no vac-
cines presently available for), is to use insect repellent. 
However, not all repellents are effective. In fact, a Swiss 
study examined 10 insect repellents and found that only 
3 were effective. Thus, before recommending a repellent, 
it is important to know its contents and to make sure that 
it has been tested and is effective. This information may 
change, so a travel medicine center should be visited for 
the most up-to-date recommendations. 
G&H  Is traveler’s diarrhea a particular concern 
in traveling IBD patients? 
GR  Yes, traveler’s diarrhea is a frequent problem in 
these patients. My colleagues and I usually give our IBD 
patients who are traveling a prescription for ciprofloxacin 
and metronidazole, and tell them to take a package of 
each on their trip. If the patient has diarrhea for more 
than 48 hours, he or she should take both drugs. Most 
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of our patients have already taken these drugs at some 
point of their disease course, so we know that they have 
no allergies and can tolerate the drugs. 
I also recommend that patients take preventive 
antibiotics if a patient has a fever for several days. How-
ever, if it is possible to go to a hospital, I suggest that the 
patient first see a doctor for fever or diarrhea, and then 
use the prescriptions I gave him or her. In addition, my 
institution has a monitored e-mail address that responds 
to questions within 24 hours. If a problem is not urgent, 
I tell patients to send an e-mail, especially if a doctor in 
another country recommends an antibiotic. 
G&H  Can any infection, including opportunistic 
infection, trigger IBD flares or cause relapse of 
IBD?
GR  The literature is contradictory on this issue. In my 
opinion, the answer is yes. 
G&H  Can air travel cause IBD flares?
GR  My colleagues and I are examining this issue because 
some of our IBD patients have been telling us that they 
always develop flares on long-distance flights. Therefore, 
we asked patients whether they ever experienced prob-
lems after long-distance flights. We found that indeed 
there were more IBD flares after high-altitude travels and 
long-distance flights. Thus, we are now trying to deter-
mine whether giving patients who report problems after 
airplane flights and high-altitude travels a prophylactic 
treatment of topical corticosteroid budesonide for 3 days 
is effective for the prevention of IBD flares via objective 
parameters, such as calprotectin measurement. 
G&H  Is it known why there might be a 
connection between air travel and IBD flares?
GR  My colleagues and I published a paper recently 
about a possible reason that hypoxia could induce flares 
of IBD. However, more research is needed to learn about 
changes in the microbiota that occur on long-distance 
flights. 
G&H  Should any IBD patients completely avoid 
travel to certain areas because of the risk of 
infection?
GR  I do not think that IBD should be a reason for chang-
ing someone’s life. Doctors should find ways to adapt their 
recommendations to the requests of patients. We should 
not intervene too much in our patients’ lives because of 
safety recommendations. For example, I had a patient on 
immunotherapy who wanted to go to a country with a 
high risk of tuberculosis. We discussed what she should 
do if she developed a fever, I gave her a tuberculosis test 
to take on the trip, and I told her to find a hospital where 
the test could be taken. It was not ideal for a patient on 
an anti-TNF agent to go to an area where tuberculosis 
has a prevalence of approximately 15%, but this was a 
trip that she definitely wanted to take. She was there for 3 
months and came back without any signs of Crohn’s flare 
or infection. 
Nevertheless, there are some areas that are a good 
idea to avoid, if possible, due to the significant risk of 
infection. For example, visits to areas with high preva-
lence of tuberculosis, such as favelas in Brazil or townships 
in South Africa, are not the best idea (besides the ethical 
aspects of such tourism), as well as high-altitude tours in 
Nepal (where there is a high prevalence of tuberculosis, 
Shigella infections, and typhoid fever). 
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